CD40LG and neoplasm: As we have previously shown the superior anti-tumor efficacy of PeptiCRAd using an unarmed adenovirus within the platform as compared to the unarmed adenovirus alone,13 here, we set up to test whether the combination of virus-encoded OX40L and CD40L has an effect on the efficacy of PeptiCRAd.